| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/13/2007 | US20070212390 Protease-resistant forms of VEGF-D, method of making and method of use |
| 09/13/2007 | US20070212378 Methods And Compositions For Mycoplasma Pneumoniae Exotoxins |
| 09/13/2007 | US20070212377 Viral particle comprising nucleotide sequences coding gB gene of infectious laryngotracheitis virus for use in generation of vaccine to prevent respiratory system disorders |
| 09/13/2007 | US20070212375 Process For Producing In Yeast Empty Viral Capsids Consisting Of Proteins Derived From Pvp2 Of The Infectious Bursal Disease Virus (Ibdv) |
| 09/13/2007 | US20070212374 Stable (fixed) forms of viral capsid proteins, and viral capsid protein fusions, preferably papillomavirus l1 proteins, and uses thereof |
| 09/13/2007 | US20070212373 Lawsonia Intracellularis 26 Kd Subunit Vaccine |
| 09/13/2007 | US20070212372 Methods for the treatment and prophylaxis of demeyelinating disease |
| 09/13/2007 | US20070212370 Soluble CD83 proteins and use thereof for the treatment and prevention of a disease or medical condition caused by dysfunction or undesired function of a cellular immune response involving T cells |
| 09/13/2007 | US20070212369 Colon Specific Genes and Proteins |
| 09/13/2007 | US20070212368 Proteins |
| 09/13/2007 | US20070212365 recombinantly produced polypeptide; contacting a vascular cell with polypeptide for inhibiting angiogeneisis |
| 09/13/2007 | US20070212362 Use of il-17 antibody for the treatment of cartilage damaged by osteoarthritis |
| 09/13/2007 | US20070212351 Novel therapeutic targets in cancer |
| 09/13/2007 | US20070212349 antibodies and antibody fragments that specifically bind a CD4-inducible HIV gp120 epitope that is enhanced by binding a co-receptor for HIV, such as chemokine receptors, used for inhibiting HIV entry into cells and inhibiting replication of HIV in mammals |
| 09/13/2007 | US20070212348 Compositions and methods for the treatment and prevention of cancer, angiogenesis, and inflammation |
| 09/13/2007 | US20070212347 Compositions and methods for treating polycystic kidney disease gene |
| 09/13/2007 | US20070212299 A gene (designated 161P2F10B) and its encoded protein which exhibits tissue specific expression in normal adult tissue and is aberrantly expressed in the cancers; medical diagnostis;, prognosis, prophylactis and/or gene therapy; tissue-target therapy; used to elicit a humoral or cellular immune response |
| 09/13/2007 | US20070212298 Use of the combination comprising temozolomide and tnf-alpha for treating glioblastoma |
| 09/13/2007 | DE60124710T2 Analoge des glucagon ähnlichen peptid-1 Analogs of glucagon-like peptide-1 |
| 09/13/2007 | DE10037270B4 Silicatein-vermittelte Synthese von amorphen Silikaten und Siloxanen und ihre Verwendung Silicatein-mediated synthesis of amorphous silicates and siloxanes and their use |
| 09/13/2007 | CA2646509A1 Compositions and methods for increasing plant tolerance to high population density |
| 09/13/2007 | CA2645177A1 Hepatitis c virus non structural fusion protein |
| 09/13/2007 | CA2644712A1 Unstructured recombinant polymers and uses thereof |
| 09/13/2007 | CA2644588A1 Truncated proteins as cancer markers |
| 09/13/2007 | CA2644255A1 Chimeric kunitz domains and their use |
| 09/13/2007 | CA2644130A1 Polynucleotide encoding a maize herbicide resistance gene and methods for use |
| 09/13/2007 | CA2644127A1 Human interferon-gamma (infgamma) variants |
| 09/13/2007 | CA2642654A1 Process for preparing human g-csf |
| 09/13/2007 | CA2638791A1 Gene encoding transcriptional inducer for maltase gene and maltose transporter gene and use thereof |
| 09/13/2007 | CA2613600A1 Natively glycosylated mammalian biological molecules produced by eletromagnetically stimulating living mammalian cells |
| 09/13/2007 | CA2606130A1 Gene encoding glycogen synthesis initiator and use thereof |
| 09/12/2007 | EP1832656A1 Method for isolating and using fungal hemolysin |
| 09/12/2007 | EP1832655A2 Methods for detecting and reversing resistance to macrocyclic lactone compounds |
| 09/12/2007 | EP1832653A1 MN gene and protein |
| 09/12/2007 | EP1832604A1 Use of IEX-1 for the treatment of glioma tumors |
| 09/12/2007 | EP1832603A2 Stabilised mRNA with increased G/C-content and optimised codon usage for gene therapy |
| 09/12/2007 | EP1832600A1 Peptides against autoantibodies associated with glaucoma and use of these peptides |
| 09/12/2007 | EP1832599A2 Albumin fusion proteins |
| 09/12/2007 | EP1831693A2 Use of pta peptides for stratification of individuals having cancer |
| 09/12/2007 | EP1831381A1 Methods to obtain recombinant proteins with increased sialylation from cells that express adenovirus e1a protein, and proteins obtained thereby |
| 09/12/2007 | EP1831376A1 Improved grain quality through altered expression of seed proteins |
| 09/12/2007 | EP1831375A1 Gene expression technique |
| 09/12/2007 | EP1831374A1 Multiple promoters and the use thereof for gene expression |
| 09/12/2007 | EP1831373A2 Recombinant production of serum albumin |
| 09/12/2007 | EP1831372A2 Neutralizing epitope-based growth enhancing vaccine |
| 09/12/2007 | EP1831371A2 Muteins of fibroblast growth factor 21 |
| 09/12/2007 | EP1831369A2 Rnai inhibition of serum amyloid a for treatment of glaucoma |
| 09/12/2007 | EP1831363A1 Expression of gamma-carboxylated polypeptides in gamma-carboxylation deficient host systems |
| 09/12/2007 | EP1831259A2 Compositions of influenza viral proteins and methods of use thereof |
| 09/12/2007 | EP1831254A2 Conjugation product |
| 09/12/2007 | EP1831253A1 Combination therapy for b cell disorders |
| 09/12/2007 | EP1831252A1 Glp-1 analog fusion protein formulations |
| 09/12/2007 | EP1831251A1 Immunogenic compositions of cyclic peptides derived from the beta-amyloid peptide |
| 09/12/2007 | EP1831250A2 L-glutamic acid-producing microorganism and a method for producing l-glutamic acid |
| 09/12/2007 | EP1831249A2 Novel genes involved in gluconeogenesis |
| 09/12/2007 | EP1831248A1 Pasteurella multocida vaccine |
| 09/12/2007 | EP1831247A2 Hetero-oligomeric hiv envelope proteins |
| 09/12/2007 | EP1831246A2 Probe for detecting nucleic acids |
| 09/12/2007 | EP1831242A1 Reduction of the content of protein contaminants in compositions comprising a vitamin k-dependent protein of interest |
| 09/12/2007 | EP1830924A1 Prevention of thrombus formation and/or stabilization |
| 09/12/2007 | EP1830872A2 Fusion proteins |
| 09/12/2007 | EP1830864A2 E1-minus adenoviruses and use thereof |
| 09/12/2007 | EP1743040A4 Hdm2-inhibitor complexes and uses thereof |
| 09/12/2007 | EP1718673B1 Albumin-purification method comprising a nanofiltration step, solution, and composition for therapeutic use containing same |
| 09/12/2007 | EP1689447A4 Gene transfer for regulating smooth muscle tone |
| 09/12/2007 | EP1581247A4 Methods and compositions for treating polycystic ovary syndrome |
| 09/12/2007 | EP1527091B1 Corn root preferential promoters and uses thereof |
| 09/12/2007 | EP1481053B1 Method of making cs6 antigen vaccine for treating, preventing, or inhibiting enterotoxigenic escherichia coli infections |
| 09/12/2007 | EP1407013B1 Mutations in ion channels |
| 09/12/2007 | EP1320542B9 Group b streptococcus polypeptides nucleic acids and therapeutic compositions and vaccines thereof |
| 09/12/2007 | EP1307564B1 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 09/12/2007 | EP1303617B1 Mutant muscle-specific enhancers |
| 09/12/2007 | EP1299541B1 Method for producing and using novel human defensins as biologically active proteins for treating infections and other illnesses |
| 09/12/2007 | EP1276885B1 Trophic conversion of obligate phototrophic algae through metabolic engineering |
| 09/12/2007 | EP1257632B1 Simultaneous stimulation and concentration of cells |
| 09/12/2007 | EP1230347B1 Method for the preparation of purified hcv rna by exosome separation |
| 09/12/2007 | EP1224266B1 Lysosomal targeting pathway enzymes |
| 09/12/2007 | EP1212366B1 Therapeutic compounds comprised of anti-fc receptor binding agents |
| 09/12/2007 | EP1154788B9 Method for indentifying compounds that modulate sister chromatid separation |
| 09/12/2007 | EP0964874B1 A lymphocyte surface receptor that binds caml, nucleic acids encoding the same and methods of use thereof |
| 09/12/2007 | EP0952158B1 Modified methylotrophic p. pastoris yeast which secretes human growth hormone |
| 09/12/2007 | EP0842268B1 Methods and compositions for identifying morphogen analogs |
| 09/12/2007 | EP0651807B1 New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents |
| 09/12/2007 | CN101035897A Vaccine for prevention and treatment of HIV-infection |
| 09/12/2007 | CN101035806A Amylin family polypeptide-6 (AFP-6) analogs and methods of making and using them |
| 09/12/2007 | CN101035805A Deglycosylated and desialidated long pentraxin PTX3 |
| 09/12/2007 | CN101035804A Modified HIV-1 peptides and use thereof in the detection of anti-HIV antibodies |
| 09/12/2007 | CN101035560A Recombinant live fowlpox virus vectors and their use in pharmaceutical compositions against hepatitis c virus |
| 09/12/2007 | CN101035440A High protein soybean meal |
| 09/12/2007 | CN101033469A Dunaliella saline TPSP gene, encoding albumen and clone method thereof, and construction method for plant conversion carrier |
| 09/12/2007 | CN101033468A Helicobacter pylori urease B subunit B cell antigen epitope polypeptide, identification method and application |
| 09/12/2007 | CN101033465A Pea albumin subunit PA1b recombination albumen and its preparing method and application |
| 09/12/2007 | CN101033464A Recombination adenovirus for expressing human particle cytolysin and its preparing method and use |
| 09/12/2007 | CN101033254A Method of purifying and combining human interleukins 12 |
| 09/12/2007 | CN101033253A Recombination Japanese lamprey oral gland Grimin protein induction cell apoptosis and its antineoplastic action |
| 09/12/2007 | CN101033252A Plant ERF transcription factor, encode gene and application thereof |
| 09/12/2007 | CN101033249A Preparation method of synthesizing bivalirudin from solid phase polypeptide |
| 09/12/2007 | CN101033248A Process of preparing calf thymus alphal |
| 09/12/2007 | CN100336911C Method for separating and purifying ice nucleus active protein from ice nucleus active bacteria |
| 09/12/2007 | CN100336908C Production of recombinant anthrax protective antigen and its special expression plasmid |